01.12.2012 Views

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

38<br />

functional deficiency of the B vitam<strong>in</strong>s, particularly pyridox<strong>in</strong>e, but also of riboflav<strong>in</strong> and thiam<strong>in</strong>e.<br />

The study <strong>in</strong>volved only 12 patients, yet the conclusion states: “But clearly, many patients with CFS<br />

are currently tak<strong>in</strong>g vitam<strong>in</strong> and other supplements with little evidence of benefit”. If the study <strong>in</strong>volved<br />

only twelve patients, to conclude that “many” patients show “little evidence of benefit” from tak<strong>in</strong>g<br />

supplements is remarkable, but it does concur with section 9.20 of the 1996 Jo<strong>in</strong>t Royal Colleges’<br />

Report (CR54), which states: “We have concerns about the use of complementary therapy and dietary<br />

<strong>in</strong>terventions”, a statement that is <strong>in</strong> accordance with the published views of HealthWatch, of which<br />

Wessely is a”lead<strong>in</strong>g member of the campaign” (see below)<br />

• advis<strong>in</strong>g Government bodies that the reported biomedical abnormalities “should not deflect the<br />

cl<strong>in</strong>ician away from the biopsychosocial approach and should not focus attention towards a search for an<br />

‘organic’ cause”, and for their recommendation that no advanced tests should be carried out on<br />

“CFS/<strong>ME</strong>” patients when it is those very tests that reveal the unequivocally organic nature of the<br />

disorder (Jo<strong>in</strong>t Royal Colleges’ Report 1996: CR54).<br />

When the Centre for Reviews and Dissem<strong>in</strong>ation (CRD) at the University of York produced its 2005<br />

Systematic Review of “evidence‐based” (mostly Wessely School) studies on behavioural <strong>in</strong>terventions for<br />

<strong>ME</strong>/CFS that was commissioned to support the 2007 NICE Cl<strong>in</strong>ical Guidel<strong>in</strong>e 53, there was much concern<br />

throughout the <strong>ME</strong>/CFS community, not least because some of the studies had used the Oxford criteria<br />

which, by def<strong>in</strong>ition, excluded those with <strong>ME</strong>.<br />

The 2005 Systematic Review was an update by Bagnall et al of the CRD’s own 2001 Systematic Review by<br />

Whit<strong>in</strong>g and Bagnall et al (JAMA 2001:286:11:1360‐1368). The 2005 Systematic Review was exposed <strong>in</strong> a<br />

comprehensive analysis by Hooper and Reid as a travesty that many people believed amounted to research<br />

misconduct (http://www.meactionuk.org.uk/FINAL_on_NICE_for_Gibson.html).<br />

Hooper and Reid po<strong>in</strong>ted out that the Bagnall et al (York) Review cited the same Wessely School papers as<br />

<strong>in</strong> their first (2001 JAMA) review but with a significant difference: virtually all the negative comments about<br />

CBT/GET that had appeared <strong>in</strong> 2001 <strong>in</strong> JAMA had been removed from the 2005 up‐dated review.<br />

This meant that the same team’s negative comments about methodological <strong>in</strong>adequacy, withdrawal rates,<br />

drop‐out rates, unacceptability of treatments and the exclusion of severely affected patients were omitted<br />

from their up‐dated review, as were their previous observations which recorded that (i) improvements<br />

might be illusory, (ii) there was no objective evidence of improvement, (iii) there was little last<strong>in</strong>g benefit<br />

from CBT, and (iv) the data <strong>in</strong> the Wessely School studies relied upon had been corrupted. Furthermore,<br />

previous reports of adverse events were excluded, as was the fact that follow‐up revealed relapse after the<br />

<strong>in</strong>terventions.<br />

Despite the acknowledgement by the 2001 team of the paucity of good quality evidence to support the<br />

recommendations of CBT/GET, none of these previous observations was mentioned <strong>in</strong> the 2005 up‐date<br />

for NICE. All negative comment, no matter how em<strong>in</strong>ent the source, was simply removed to the extent<br />

that it seemed <strong>in</strong>escapable that Bagnall et al had been subjected to covert external <strong>in</strong>fluence. As Hooper<br />

and Reid noted: “It would be most unfortunate if a powerful outside <strong>in</strong>fluence has been able to impose his<br />

own concepts on a team of supposedly neutral reviewers”.<br />

Even more disturb<strong>in</strong>gly, not only had those caveats disappeared from the 2005 version, but citation of the<br />

JAMA 2001 article <strong>in</strong> which they had appeared was also deleted. In 2001 Bagnall’s work appeared <strong>in</strong> one<br />

of the world’s most prestigious medical journals (JAMA) but <strong>in</strong> 2005 she disowned her own 2001 work<br />

and there is abundant evidence that <strong>in</strong> 2005 Bagnall was prevailed upon to dilute or delete op<strong>in</strong>ions she<br />

held <strong>in</strong> 2001, a matter that some considered to be research misconduct. What rationale could possibly<br />

underlie this astonish<strong>in</strong>g self‐censorship?

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!